Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and ...

Colossal Biosciences has focused on identifying key traits of extinct animals by studying ancient DNA, with a goal to genetically "engineer them into living animals," said CEO Ben Lamm.

Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP)—a life ...

The quest to resurrect the woolly mammoth on Earth has taken another, well, small step with the creation of the Colossal ...

Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and animals. To better ...

The animals, the first to have been created by Colossal Biosciences, have fluffy coats and curly whiskers.

Colossal Biosciences has altered several genes in mice to make them look more mammoth-like, but the company is far from its ...

DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...

The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...

Researchers at the Arc Institute, Stanford University, and NVIDIA have developed Evo 2, an advanced AI model capable of ...

CEOs, CIOs and CFOs are finding that “deep tech” is actively driving business innovation and profitability. From AI models ...

After an illustrious career, including 12 years as director of the NIH and leading the HGP consortium, Francis Collins announces his sudden resignation.